Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Medical Data Center for Research and Innovation.
J Pediatr Gastroenterol Nutr. 2021 Jul 1;73(1):86-92. doi: 10.1097/MPG.0000000000003104.
Ascites is a pathologic buildup of fluid in the peritoneal cavity. Knowledge is lacking in clinical outcome in pediatric patients with ascites. We aim to identify and assess clinical variables, associated with morbidity and mortality in pediatric patients who are hospitalized with ascites.
A retrospective cohort study was performed on patients ages 0 to 21 hospitalized at Johns Hopkins Hospital between 1983 and 2010 with an ICD-9 discharge diagnosis of ascites (789.5, 789.51, 789.59). A total of 518 pediatric patients were studied, all with a diagnosis of ascites during hospitalization. Study outcomes included hospital length of stay (LOS) as a proxy for morbidity and death at hospital discharge for mortality. Variables analyzed included demographic data, ascites etiology and grade, comorbidities, and laboratory markers. Variables were analyzed by log-linear regression and competing risk model.
Among the 3 age groups (0-5, 6-12, and 13-21), the 0 to 5 age group experienced significantly increased LOS (P < 0.001) and mortality (P = 0.027). Ascites etiology of veno-occlusive disease (VOD) and the presence of hydrothorax or thrombocytopenia was also significantly associated with increased LOS. Ascites with the etiology of congestive hepatopathy and the presence of grade 3 ascites, hepatic encephalopathy, hepatorenal syndrome, hydrothorax, hyponatremia, and thrombocytopenia were associated with increased mortality. Additionally, black pediatric patients have an increased risk of mortality (P = 0.027). Other factors including sex, leukopenia, portal vein thrombosis, and splenomegaly were not associated with LOS or mortality.
Morbidity and mortality in pediatric patients hospitalized with ascites are associated with specific demographic and clinical factors. Further studies are required to apply this knowledge to predict the clinical outcomes.
腹水是腹腔内病理性积液的积聚。在患有腹水的儿科患者中,临床结局的相关知识尚缺乏。本研究旨在确定并评估与住院腹水患儿发病率和死亡率相关的临床变量。
对 1983 年至 2010 年期间在约翰霍普金斯医院住院的年龄在 0 至 21 岁的 ICD-9 腹水出院诊断为(789.5、789.51、789.59)的患者进行回顾性队列研究。共研究了 518 名患有腹水的儿科患者,所有患者在住院期间均被诊断为腹水。研究结果包括住院时间(LOS)作为发病率的替代指标和出院时的死亡率。分析的变量包括人口统计学数据、腹水病因和分级、合并症和实验室标志物。通过对数线性回归和竞争风险模型分析变量。
在 3 个年龄组(0-5、6-12 和 13-21)中,0-5 岁年龄组的 LOS(P<0.001)和死亡率(P=0.027)显著增加。VOD 为腹水病因和存在胸腔积液或血小板减少症也与 LOS 增加显著相关。病因充血性肝病变和腹水分级 3、肝性脑病、肝肾综合征、胸腔积液、低钠血症和血小板减少症与死亡率增加相关。此外,黑人儿科患者的死亡率增加(P=0.027)。其他因素,包括性别、白细胞减少症、门静脉血栓形成和脾肿大,与 LOS 或死亡率无关。
住院腹水患儿的发病率和死亡率与特定的人口统计学和临床因素相关。需要进一步研究以将这些知识应用于预测临床结局。